Search
Close Search

Cxbladder is a Genomic Urine Test that Improves Bladder Cancer Detection Accuracy

Cxbladder is a non-invasive and easy-to-use genomic urine test optimized for the detection and management of bladder cancer.

Cxbladder is a non-invasive genomic urine test optimized for the detection and management of bladder cancer. The test combines clinical risk factors with gene expression markers to quickly and accurately detect the presence or absence of bladder cancer.

You should consider a Cxbladder test when you’ve seen blood in your urine, when tests reveal you have blood in your urine, or when you’ve had bladder cancer and are being monitored for recurrence. Cxbladder provides greater certainty, resolving diagnostic ambiguity and improving overall detection accuracy. As a non-invasive surveillance alternative, the test can reduce the frequency of cystoscopy required in many patients.

Cxbladder’s proven accuracy makes it a reliable choice. With performance validated in over 20 peer-reviewed studies, Cxbladder is covered by Medicare and trusted by over 2,000 urologists in more than 80,000 patients. In New Zealand, the test is available to 70% of the population through public healthcare. 

Take control of your care. Cxbladder comes with the option of in-home sampling for comfort and convenience, and provides reliable results that will help you and your doctor make informed diagnosis and management decisions.
Learn more about Cxbladder     Contact us for more information

Bladder Cancer Detection

In the United States, bladder cancer is the sixth most common cancer, with over 80,000 new cases reported annually. The most common sign of bladder cancer is blood in urine (or hematuria), however patients may experience a range of other symptoms such as urinary irritation and/ or changes in the frequency, urgency, or ease of urination.

Several tests and procedures are available to determine whether an individual has bladder cancer or to establish an alternative diagnosis. Some of these clarify the presence of symptoms (such as hematuria) and others identify alternative causes of these symptoms (such as an infection). Importantly, these tests and procedures are used in combination to determine an overall diagnosis.

Learn more about bladder cancer symptoms     Browse our overview of bladder cancer detection



Tests and procedures used in detection, rule-out, and diagnosis include:

Urine Test Detection

Urine-based Tests
Non-invasive urine-based tests can be used to determine if blood or other substances are present in a sample, whether an infection may be the root cause of symptoms, and if microscopic cancer or pre-cancer cells are visible. Genomic tests like Cxbladder analyse biomarker genes to improve overall bladder cancer detection accuracy, or to rule out cancer, reducing the need for further invasive procedures.
Learn more about urine test detection

Cystoscopy

Cystoscopy
Cystoscopy involves inserting a thin tube with a light and camera through the urethra to look inside the bladder. This procedure is usually recommended if cancer is suspected.
Learn more about cystoscopy

Ultrasound

Imaging
Imaging techniques like an ultrasound, which use high frequency waves to produce images of internal organs and tissue, and CT scans, which use x-rays to obtain cross-sectional images of the body, are often used to determine if abnormalities are present, particularly in the upper urinary tract and kidneys.
Learn more about imaging techniques

Last Updated: 25 Jun 2021 11:29 am